"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.
Vaxman I, Abeykoon J, Dispenzieri A, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Reeder C, Sher T, Hayman S, Kourelis T, Warsame R, Muchtar E, Leung N, Go R, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Kristen M, Kapoor P, Gertz MA.
Vaxman I, et al. Among authors: kyle ra.
Blood Cancer J. 2021 Dec 7;11(12):196. doi: 10.1038/s41408-021-00592-3.
Blood Cancer J. 2021.
PMID: 34876555
Free PMC article.